The effect of aerobic exercise as auxiliary therapy on the improvement of the negative and cognitive symptoms of patients with chronic schizophrenia in a randomized clinical case-control study .
- Conditions
- Schizopherenia disorder.Schizophrenia, schizotypal and delusional disorders(F20-F29)F20-29
- Registration Number
- IRCT20190316043072N1
- Lead Sponsor
- Karaj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Having diagnostic criteria for DSM-V for patients with schizophrenia
The PANSS60 is the lowest score
Age 18 to 05 years old
Obtain informed consent from patient care at least 2 years after the onset of the disease
Minimum patient score based on Negative subscore 20
Significant neurological or organoleptic disease, cardiovascular disease and history of cardiac surgery, or any cardiovascular procedure, clinically and laboratory examinations, and case study and biographies of the family.
There is another diagnosis in axis I based on DSM-Vo IQ of less than 70 based on Clinical Clinical suspiciono Drug abuse (except nicotine and caffeine)
An anti-psychoactive oral intake in the past week or an anti-psychoactive effect in the past montho Get the ECT in the last two weekso Having Major Depression Criteria or Top 4 Scores Based on PANSS Depression
The desire and suicide attempt in Hamiltono Patients drinking alcohol simultaneously
Patients with a history of drug use in the last 6 months
Women of childbearing age are not admitted without adequate prophylaxis
CHF and liver patients
All patients are undergoing ECG and biochemical tests for liver and kidney disease.
All patients undergo five stages including basal and weekly visits in weeks 2- 4 and 6.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Aerobic exercise. Timepoint: Weeks: 0, 2, 4, 6 and 8. Method of measurement: PANSS/ Brain MRI.;Negative and cognitive symptoms. Timepoint: Weeks: 0, 2, 4, 6 and 8. Method of measurement: PANSS/ Brain MRI.
- Secondary Outcome Measures
Name Time Method